Increasing Diagnosis Rates and Growing Use of Key Agents Such as Pfizer's Lyrica Will Drive Eight Percent Annual Growth in the Fibromyalgia Drug Market Through 2018
WALTHAM, Mass., July 13 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that increased use of key agents such as Pfizer's Lyrica, Eli Lilly/Boehringer Ingelheim's Cymbalta/Xeristar/Ariclaim and Forest Labora...
Current and Emerging Therapies Have No Advantage Over Pfizer's Lyrica in Their Effect on Patients' Quality of Life in the Treatment of Diabetic Neuropathy
However, Owing to Safety and Delivery End Points, Drugs from Eli Lilly and
Boehringer Ingelheim Will Remain as the Gold Standard Treatments, According to a New Report from Decision Resources
WALTHAM, Mass., March 13 /PRNewswire/ -- Decision Resources, one of the
world's leading r...
Common Drug Eases Restless Legs Syndrome
also improves quality of sleep for patients, study...eguero said.
He also noted that patients taking lyrica
had improved quality of sleep. "Other drugs for RL...ve not been able to improve sleep."
This use of lyrica
is an off-label one, Garcia-Borreguero cautioned. ...
AstraZeneca's Purplepill.com Tops the List of Most Visited Pharmaceutical Brand Web Sites in Q2 2008
... 3 % Veramyst (veramyst.com) N/A 538 N/A Januvia (januvia.com) 118 507 329 % lyrica
(lyrica.com) 368 501 36 % Topamax (topamax.com) 361 498 38 % Seroquel (seroquel....
Newly Labeled Therapies for Neuropathic Pain, Including Drugs From Pfizer and Eli Lilly, Will Drive Growth in the Chronic Pain Drug Market
...eled to treat neuropathic pain, including Pfizer's lyrica
Lilly's Cymbalta will be a key driver of g...ished drugs like amitriptyline, new agents
such as lyrica
and Cymbalta have the safety and efficacy data fro... the chronic pain drug market
by 2011 and sales of lyrica
will exceed $2 billion by 2016."
The chronic pai...
Royalty Pharma Acquires a Portion of Northwestern University's Royalty Interest in Lyrica(R) for $700 Million
... and improvements to existing facilities; and for other
"Essentially, we are converting a potential stream of future royalty
revenues from lyrica
into an immediate cash payment," Sunshine explained.
"We continue to believe strongly in Lyrica's potential and Northwestern
retains a large portion o...
US Neuropathic Pain Market Value Doubles to $5 Billion by 2018
...ding to US Neuropathic Pain, a report released today by
WWMR, Inc. Growth over the past four years has been driven largely by the
successful launch of lyrica
(pregabalin) for diabetic neuropathic pain and
post-herpetic neuralgia in December 2004 along with its 2007 approval for
fibromyalgia, as well as the ...
Sosei Announces Completion of Phase II Trial of AD 337 in Fibromyalgia Syndrome
...syndrome is not well understood but
serotonin (5-HT) and noradrenalin (NA) dysfunction is believed to be a
contributory factor. To date only one drug, lyrica
specifically indicated for FMS and approval in the USA was only granted in
June 2007. Accordingly, therapy continues to be based on a ...